Seeing more good news about the fight against the novel coronavirus comes like a breath of fresh air amidst the global crisis that’s been triggered by this terrible pandemic.
Earlier today, we reported that the very first COVID-19 vaccine that’s been tested in the US managed to revive people’s immunity just the way in which experts were hoping when they created it. The vaccine is set to advance to the final testing phase this month and this triggered enthusiasm all over the world.
Existing drug can downgrade the dangers of coronavirus
Now, it’s been also revealed that there’s an exciting medicine that has the ability to downgrade the danger levels of coronavirus to the ones of a simple, common cold. This is what a Jwerusalen researcher has been claiming after he tested it on infected human tissue.
The Times of Israel notes: “Prof. Yaakov Nahmias says that his research shows that the novel coronavirus is so vicious because it causes lipids to be deposited in the lungs, and that there is a solution to undo the damage: a widely-used anti-cholesterol drug called fenofibrate.”
“If our findings are borne out by clinical studies, this course of treatment could potentially downgrade COVID-19’s severity into nothing worse than a common cold,” Nahmias said, as cited by the online publication mentioned above.
Why choose this medicine
He explained to the same online magazine how experts came up with this idea to try this medicine:
“The question is why this new coronavirus is so different from its close relatives that just cause a common cold. What we see is that this virus really changes lipid metabolism in the human lungs,” he said.
He continued and said: “The new coronavirus causes tiny lipid droplets to accumulate in the lungs, something you don’t normally see in the lungs in any significant quantity.”
Stay tuned for more breaking news and stay safe.